Latest Headlines

  1. Groundbreaking ARUP Research Clarifies Clinical Value Of Atypical Cell-Free DNA Screening Results 9/8/2026

    An extensive, first-of-its-kind research study by ARUP Laboratories clarifies the clinical value of atypical findings from prenatal cell-free DNA (cfDNA) screening and their impact on pregnancy outcomes.

  2. Agilent Expands Digital Pathology Offering With U.S. Launch Of The Agilent S540MD Slide Scanner System 9/4/2026

    Agilent Technologies Inc. today announced the U.S. launch of the Agilent S540MD Slide Scanner System, a whole slide imaging (WSI) digital scanner, following FDA clearance.

  3. PixCell Medical Expands Into Canada Through Partnership With Inter Medico Following Health Canada Class III Licence For HemoScreen 9/2/2026

    PixCell Medical today announced its expansion into the Canadian market following the receipt of a Health Canada Class III Medical Device License for its HemoScreen™ point-of-care hematology analyzer and a new distribution partnership with Inter Medico.

  4. Onymos And Vanta Diagnostics Collaborate To Scale Intelligent Lab Intake 9/2/2026

    Onymos, a leader in intelligent document processing for precision medicine, and Vanta Diagnostics, a leading provider of molecular laboratory services, today announced the results of their collaboration, demonstrating how using AI-assisted intake increased operational efficiency by up to 72%, expanded laboratory capacity by more than 300 samples per day, and reduced accessioning errors by 40%.

  5. Thermo Fisher Scientific Launches Multiskan Ease Absorbance Microplate Reader To Help Simplify Protein, Cell And Microbial Analysis 9/2/2026

    Thermo Fisher Scientific today announced the launch of the Thermo Scientific Multiskan Ease Absorbance Microplate Reader, designed to support protein quantification, enzyme-linked immunosorbent assays (ELISAs), cell viability studies, microbial growth monitoring and other routine laboratory applications with simplified operation and dependable performance.

  6. Invivoscribe Begins Commercial Shipments Of PrepQuant Systems, Enabling High-Sensitivity Sample Preparation For MRD Testing 9/2/2026

    Invivoscribe, a global leader in precision diagnostics and measurable residual disease (MRD) testing, today announced that commercial shipments of the PrepQuant System have begun in North America.

  7. New Peer-Reviewed Study Advances CIZ1B Blood Test For Early Lung Cancer Detection 9/1/2026

    Cizzle Bio Inc., a biotechnology company advancing biomarker blood tests for early cancer detection, has announced the publication of new peer-reviewed research supporting the clinical utility of the CIZ1B biomarker for early lung cancer detection.

  8. BillionToOne Launches Northstar Origin, A New Liquid Biopsy Test To Help Identify Tissue Of Origin 9/1/2026

    BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced the launch of Northstar Origin™, a new liquid biopsy add-on test for tissue-of-origin prediction, along with the expansion of its Northstar Select® panel from 84 to 102 genes to cover genes that are included in recent and upcoming FDA approvals.

  9. Metrohm Launches OMNIS IC 9/1/2026

    Metrohm introduces OMNIS IC, the next-generation ion chromatography system designed to combine maximum flexibility, automation, and reliability on a single analytical platform. Built on a modular hardware concept and powered by intuitive software, OMNIS IC addresses both current and future analytical demands while ensuring efficiency and reproducible results.

  10. Agilent Introduces The Cary 635 FTIR Spectrometer 9/1/2026

    Agilent Technologies, Inc. today announced the launch of the Agilent Cary 635 FTIR spectrometer, setting a new standard for compact, high-performance Fourier transform infrared (FTIR) analysis.